» Articles » PMID: 26857072

Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2016 Feb 10
PMID 26857072
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The application of the CRISPR-Cas9 system for genome engineering has revolutionized the ability to interrogate genomes of mammalian cells. Programming the Cas9 endonuclease to induce DNA breaks at specified sites is achieved by simply modifying the sequence of its cognate guide RNA. Although Cas9-mediated genome editing has been shown to be highly specific, cleavage events at off-target sites have also been reported. Minimizing, and eventually abolishing, unwanted off-target cleavage remains a major goal of the CRISPR-Cas9 technology before its implementation for therapeutic use. Recent efforts have turned to chemical biology and biophysical approaches to engineer inducible genome editing systems for controlling Cas9 activity at the transcriptional and protein levels. Here, we review recent advancements to modulate Cas9-mediated genome editing by engineering split-Cas9 constructs, inteins, small molecules, protein-based dimerizing domains, and light-inducible systems.

Citing Articles

Inhibition of RNA-binding proteins with small molecules.

Wu P Nat Rev Chem. 2023; 4(9):441-458.

PMID: 37127961 DOI: 10.1038/s41570-020-0201-4.


Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management.

Allemailem K, Almatroodi S, Almatroudi A, Alrumaihi F, Al Abdulmonem W, Al-Megrin W Int J Mol Sci. 2023; 24(8).

PMID: 37108214 PMC: 10139162. DOI: 10.3390/ijms24087052.


A Split CRISPR/Cas13b System for Conditional RNA Regulation and Editing.

Xu Y, Tian N, Shi H, Zhou C, Wang Y, Liang F J Am Chem Soc. 2023; 145(9):5561-5569.

PMID: 36811465 PMC: 10425183. DOI: 10.1021/jacs.3c01087.


Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells.

Yang Y, Li D, Wan F, Chen B, Wu G, Li F Cells. 2022; 11(22).

PMID: 36429003 PMC: 9688475. DOI: 10.3390/cells11223574.


Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems.

Shams F, Bayat H, Mohammadian O, Mahboudi S, Vahidnezhad H, Soosanabadi M Bioimpacts. 2022; 12(4):371-391.

PMID: 35975201 PMC: 9376165. DOI: 10.34172/bi.2022.23871.